Medipacs, a Tucson, Ariz.-based developer of medical devices using hydrogel polymers, has raised $1.65 million in first-round funding led by Mesa Verde Venture Partners.
Medipacs, Inc., a
Medipacs Inc. CEO, Mark McWilliams comments: “We are very pleased with the tremendous response by interested investors in our novel disposable infusion technology and the unique business model we have developed for its commercialization.”
Mesa Verde's Managing Member, Daniel C. Wood, CFA, states, “We have a high regard for the team, the science and the Board assembled by the Company We are very pleased to be the first institutional investor in Medipacs.”
Mesa Verde Venture Partners is a biomedical, seed/start-up venture capital fund based in
For additional company information, please contact Kent Smith, Vice President of Marketing at 858 228 0348.
Medipacs, Inc. is a